Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

JAK inhibitors offer new hope for treating severe alopecia areata.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Antioxidants might help manage Long Covid by addressing oxidative stress and nutrient imbalances.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.